🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSurvodutide (GCG/GLP-1) — anyone have experience? Page 4

Survodutide (GCG/GLP-1) — anyone have experience?

stefan_berlin Sat, Mar 28, 2026 at 5:44 AM 16 replies 838 viewsPage 4 of 4
mike.trainer_LA
Senior Member
1,567
7,234
Apr 2024
Los Angeles, CA
Apr 4, 2026 at 9:25 PM#16
SleepDoc_PDX said:
The mechanism and the magnitude are separate questions.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

Last edited: Apr 5, 2026 at 1:25 AM
44 19Dr.AddMedPHL, newstart_MO, mia_MS2 and 41 others
Reply Quote Save Share Report
kim_atl_prep
Member
312
1,345
Aug 2024
Atlanta, GA
Apr 5, 2026 at 5:58 PM#17
NicoleRaleigh said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Mine went the same way, slower.

43 18BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 40 others
Reply Quote Save Share Report
MarkLI_maint
Member
534
2,345
Jun 2024
Long Island, NY
Apr 6, 2026 at 2:31 PM#18
NicoleRaleigh said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

Adding the part of the answer the thread has not reached. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

42 17HPLC_Greg, LibrarianMeg, bri_stats and 39 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Apr 7, 2026 at 11:03 AM#19

Adding the numbers, since they settle part of this. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

Last edited: Apr 7, 2026 at 2:03 PM
41 16emily_PDX, Dr.SleepRoch, laura_annarbor and 38 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 8, 2026 at 7:35 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Report rather than reply if it drifts again.

19 19PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 16 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register